The role is accountable for creating a differentiated strategy and positioning, generating deep customer and market insights, supporting and informing development priorities and investment decisions for the clinical and evidence programme, delivering market-shaping programmes to maximise patient and business impact, and conducting commercial planning and preparations through to launch and beyond. Reflecting the asset's earlier stage of development, the role will provide proactive commercial and strategic input to development priorities and decisions, working closely with Clinical Development, Global Medical Affairs, Regulatory Affairs, Diagnostics, Pricing and Market Access, Global Analytics & Insights, Digital, Corporate Affairs, regional and country teams, and other partners.